Acer therapeutics reports q1 loss per share of $0.49

Acer therapeutics reports first quarter 2020 financial results and provides corporate update.q1 loss per share $0.49.q1 earnings per share estimate $-0.40 -- refinitiv ibes data.ended q1 with $7.0 million in cash and cash equivalents.

ACER Ratings Summary

ACER Quant Ranking